期刊文献+

乙型肝炎病毒L02细胞转染模型的建立与鉴定

Establishment and identification of L02 cell line transfected by HBV genome
原文传递
导出
摘要 我们以L02细胞为基础,利用基因重组技术构建含1.3倍加长乙型肝炎病毒(HBV)全基因组的表达质粒pcDNA-HBV,进行基因转染,获得了类似HepG2 2.2.15(简称2.2.15细胞)(HepG2转染HBV DNA后所得)具有复制和分泌HBV能力的HBV转染细胞模型.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2005年第9期702-703,共2页 Chinese Journal of Hepatology
基金 国家自然科学基金(39970858)
  • 相关文献

参考文献2

二级参考文献13

  • 1Blum HE, Zhang ZS, Galun E, et al. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol, 1992, 66: 1223-1227.
  • 2Ying C, De Clereq E, Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. J Viral Hepat, 2000, 7: 79-83.
  • 3Price PM, Banerjee R, Jeffrey AM, et al. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine. Hepatology, 1992,16: 8-12.
  • 4Oberhaus SM, Newbold JE. Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J Virol, 1993, 67: 6558-6566.
  • 5Howe AY, Robins MJ, Wilson JS, et al. Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2', 3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.Hepatology, 1996, 23: 87-96.
  • 6Seeger C, Mason WS. Hepatitis B Virus Biology. Microbiology Mol Biol Rev, 2000, 64: 51-68.
  • 7Morrey JD, Bailey KW, Korba BE, et al. Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral. 1999, 42: 97-108.
  • 8Junker-Niepmann M, Bartenschlager R, Schaller H. A short cisacting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMEO,1990, 9: 3389-3396.
  • 9Guidotti LG, Matzke B, Schaller H, et al. High-level hepatitis B virus replication in transgenic mice. J Virol, 1995, 69: 6158-6169.
  • 10Kajino K, K.amiya N, Yuasa S, et aL Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse. Application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Biochem Biophys Res Commun, 1992, 241: 43-48.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部